Low circulating miR-190a-5p predicts progression of chronic kidney disease.
Saved in:
| Title: | Low circulating miR-190a-5p predicts progression of chronic kidney disease. |
|---|---|
| Authors: | Baird DP; Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom., Zang J; Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, United Kingdom., Connor KL; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Teenan O; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Reck M; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Cairns C; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Sutherland C; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Bell RMB; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Traynor JP; Glasgow Kidney and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Wong R; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom., Ferenbach DA; Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom., Hughes J; Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom., Mark PB; Glasgow Kidney and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom.; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Maxwell AP; Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, United Kingdom., McKay GJ; Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, United Kingdom., Simpson DA; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom., Conway BR; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom., Denby L; Centre for Cardiovascular Science, Edinburgh Kidney, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, United Kingdom. Laura.Denby@ed.ac.uk. |
| Source: | Nature communications [Nat Commun] 2025 Oct 15; Vol. 16 (1), pp. 9154. Date of Electronic Publication: 2025 Oct 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-64168-6 |
